Impact of treatment size and therapy type in phase II clinical trials of non-small cell lung cancer

Impact of treatment size and therapy type in phase II clinical trials of non-small cell lung cancer

This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2023.

Dettagli Bibliografici
Autore principale:	Rahman, Tasnim
Altri autori:	Azam, Faruque
Natura:	Tesi
Lingua:	English
Pubblicazione:	Brac University 2024
Soggetti:	Efficacy endpoint Clinical trial Treatment size Lung cancer Lung > Cancer > Treatment
Accesso online:	http://hdl.handle.net/10361/22174

Documenti analoghi

Effect of performance status on efficacy endpoints in phase II trials of non-small cell lung cancer
di: Paul, Pulock
Pubblicazione: (2024)

Efficacy analysis of tyrosine kinase inhibitor combinations in phase II clinical trials of non-small cell lung cancer
di: Flora, Sanzida Alam
Pubblicazione: (2024)

Efficacy analysis and prediction in phase II clinical trials of non-small cell Lung Cancer
di: Hoque, Ismoth Ara
Pubblicazione: (2024)

Pooled analysis of response rate and overall survival of Tyrosine Kinase inhibitor combinations in phase II clinical trials of non-small cell lung cancer
di: Karim, Samia Binte
Pubblicazione: (2024)

Potential of liposomes for the treatment of lung cancer- a review
di: Mim, Shanzida
Pubblicazione: (2023)

A review on targeted therapies for lung cancer
di: Ashraf, Anushey
Pubblicazione: (2023)

A review on recent advances in drugs for lung cancer treatment
di: Noor, Fouzia
Pubblicazione: (2024)

Bioinformatics analyses of key regulators of NF-κB pathway in relation with small cell lung carcinoma
di: Zangmo, Thinley
Pubblicazione: (2024)

Molecules associated with the development of lung cancer
di: Rahman, Adree, et al.
Pubblicazione: (2023)

Protein biomarkers for Lung Cancer: a bioinformatic approach
di: Jeba, Joynob
Pubblicazione: (2017)

Targeted treatment in patients with non-small cell lung cancer: Use of Bevacizumab and its Biosimilars
di: Tania, Umme
Pubblicazione: (2023)

Pooled analysis of progression-free survival and overall survival in phase II clinical trials of breast cancer
di: Shobnam, Sohana
Pubblicazione: (2024)

Recent developments in the Adeno-Associated Viral Gene Therapy for Non-Small Cell Lung Cancer during the past 20 years
di: Razna, Amrin Islam
Pubblicazione: (2019)

Immunotherapy in the Management of Lung Cancer
di: Tasnim, Humayra
Pubblicazione: (2022)

A cross-sectional study on risk factors, symptoms, treatment and management strategies of lung cancer in a tertiary care cancer hospital of Bangladesh
di: Pial, Sazia Afrin
Pubblicazione: (2018)

Computational insights into molecular docking strategies for non-small cell lung cancer drug discovery
di: Das, Reshita
Pubblicazione: (2024)

An overview of the clinical management and challenges of treatments for the patients diagnosed with COVID-19 and lung carcinoma
di: Bristy, Israt Zerin
Pubblicazione: (2021)

A case study of lung cancer patients in term of various risk factors in context of Bangladesh
di: Shabnam, Musharrat
Pubblicazione: (2018)

Current practice and approaches of immunotherapy in Cancer treatment
di: Khondokar, Faiza
Pubblicazione: (2022)

Biosimilar in lymphoma treatment
di: Tanisha, Mehrin Haque
Pubblicazione: (2021)

Lung cancer detection and classification using machine learning
di: Arefin, Mahbubul, et al.
Pubblicazione: (2023)

Recent advancement on breast cancer detection and treatment
di: Rahman, Sanjida
Pubblicazione: (2023)

Targeting BRAFV600E in the treatment of CRC
di: Roja, Mashwiyat Samrin
Pubblicazione: (2024)

RIPK pathway, as a potential target, for cancer treatment - a review
di: Jahan, Nusrat
Pubblicazione: (2024)

Score based risk assessment of lung cancer and its evaluation for Bangladeshi people
di: Mukti, Roushney Fatima, et al.
Pubblicazione: (2016)

Lung cancer immunosuppression and therapeutic targeting of myeloid- derived suppressor cells
di: Nandy, Aditi
Pubblicazione: (2022)

Potential phytochemicals and dietary components for the prevention and treatment of skin cancer: A review
di: Muntaha, Habibatul
Pubblicazione: (2023)

Palliative care services in cancer treatment: a study of the current scenario in Dhaka
di: Rahman, Qazi Ashrafur
Pubblicazione: (2018)

Evaluation of genetics of cancer predisposition in patients and efficacy of various chemotherapeutic drugs in Bangladesh
di: Hossain, Safa Binte
Pubblicazione: (2019)

ক্যান্সার : মৃত্যু অবধারিত নয় /
di: করীম, আবুল বাশার মোহাম্মদ ফজলুল

Dendritic cell vaccine for the treatment of cancer
di: Haque, Tanzila
Pubblicazione: (2023)

Prevalence and application of an evolving genome editing tool “CRISPR/Cas System” in cancer research and treatment
di: Shaikat, Mahdi Mubin
Pubblicazione: (2023)

A comprehensive review on drug repurposing in cancer treatment
di: Sarkar, Onusree
Pubblicazione: (2024)

Stem cells as therapeutic carrier in cancer treatment
di: Anika, Mysha Yeasmin
Pubblicazione: (2022)

A review on non-polyphenolic and terpenoid phytoconstituents with antioxidant and cytotoxic potential
di: Ahmed, Kazi Zeba
Pubblicazione: (2021)

Genetic innovations for breast cancer treatment : a review of gene therapy strategies and future implications
di: Hasan, Sakib
Pubblicazione: (2024)

A review on nanoparticles based drug delivery in cancer treatment: advantages & challenges
di: Nahar, Kamrun
Pubblicazione: (2023)

Natural products and their combinatory effects in breast cancer treatment
di: Siddique, Md. Ayman
Pubblicazione: (2021)

Targeted therapeutic options in the treatment of Breast Cancer
di: Alam, Kazi Tasnuva
Pubblicazione: (2022)

A review on artemisinin based combination therapy for the treatment of Malaria
di: Chowdhury, Amina Ferdous
Pubblicazione: (2020)